NCT05715320 Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05704738 A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT05704205 The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05696392 The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. Status TERMINATED Phase PHASE4
NCT05694884 Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab Status RECRUITING Phase PHASE2
NCT05692843 Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response Status UNKNOWN Phase PHASE4
NCT05689151 A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis. Status RECRUITING Phase N/A
NCT05688735 Assessment of the Effect of Coconut and Sunflower Seed Oil Derived Isosorbide Diseters and Colloidial Oatmeal Status UNKNOWN Phase NA
NCT05680298 Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China Status COMPLETED Phase PHASE4
NCT05676242 A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis Status RECRUITING Phase PHASE3
NCT05669794 An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05662800 Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food Allergy Status UNKNOWN Phase N/A
NCT05656911 A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05651711 A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) Status COMPLETED Phase PHASE3
NCT05644691 Impact of the Daily Use of Emollient on Corticosteroids Consumption in Patients With Atopic Dermatitis Status COMPLETED Phase N/A
NCT05642208 Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05638165 A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112 Status COMPLETED Phase PHASE1
NCT05636839 UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3 Status RECRUITING Phase NA